FOXP3 and breast carcinoma: There was no significant association between the response to NET and CD8 + T cell counts (p = 0.969), FOXP3 + T cell counts (p = 0.215), or the FOXP3+/CD8 + T cell ratio (p = 0.093) in pre-treatment breast cancers (Fig. 2a–c).